BSEM
Biostem Technologies Inc
Price:  
12.63 
USD
Volume:  
50,670
United States | Pharmaceuticals

BSEM WACC - Weighted Average Cost of Capital

The WACC of Biostem Technologies Inc (BSEM) is 6.5%.

The Cost of Equity of Biostem Technologies Inc (BSEM) is 6.55%.
The Cost of Debt of Biostem Technologies Inc (BSEM) is 4.5%.

RangeSelected
Cost of equity5.7% - 7.4%6.55%
Tax rate26.2% - 27.0%26.6%
Cost of debt4.5% - 4.5%4.5%
WACC5.7% - 7.3%6.5%
WACC

BSEM WACC calculation

CategoryLowHigh
Long-term bond rate3.9%4.4%
Equity market risk premium4.6%5.6%
Adjusted beta0.40.45
Additional risk adjustments0.0%0.5%
Cost of equity5.7%7.4%
Tax rate26.2%27.0%
Debt/Equity ratio
0.020.02
Cost of debt4.5%4.5%
After-tax WACC5.7%7.3%
Selected WACC6.5%

BSEM's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for BSEM:

cost_of_equity (6.55%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.4) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.